The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Share Option Scheme and Grant to PDMR

4 Dec 2017 07:00

RNS Number : 2141Y
Cronin Group PLC
04 December 2017
 

4 December 2017

Cronin Group Plc

("Cronin" or the "Company")

Adoption of New Share Option Scheme

and

Grant of Options to a PDMR

 

Cronin Group Plc, the AIM listed company focusing on digitizing chemistry, announces the adoption of the Cronin Group Plc Share Option Plan 2017 (the "Plan") and the grant of options to all employees of its subsidiary, Cronin 3D Limited, including a person discharging managerial responsibilities ("PDMR").

 

The Plan is being introduced to recruit, retain and incentivise Directors and employees of the Company and its subsidiaries (the "Group"). The number of options that may be awarded under the Plan is limited to a maximum number of new ordinary shares of 0.01p each in the Company ("Ordinary Shares") representing 11 per cent. of the Company's issued share capital, and may be issued as tax-effective enterprise management incentives where appropriate.

The Board has approved the terms of the Plan and, authorised an initial award of options to employees on 1 December 2017 (the "Date of Grant") over 1,936,667 Ordinary Shares at an exercise price of 2.13p (being the closing price on 30 November 2017, the business day preceding the Date of Grant). The award represents approximately 0.35 per cent. of the Company's issued share capital.

Of the 1,936,667 options granted under the Plan, 677,871 vest on the date of grant. The balance vest in monthly instalments until either three years from the Date of Grant, or in the case of certain longer serving employees, from the earlier date of three years from the end of each of the employees' respective historic probation periods. The options are all exercisable for 10 years from the Date of Grant and the Plan will expire on 30 November 2027.

Within the award of options referred to above, Steve Coles, the Company's Chief Technology Officer, who is identified as a PDMR, has been granted options over a total of 1,666,667 Ordinary Shares, of which 648,148 vest on the Date of Grant and vesting of the balance is in monthly instalments thereafter until 1 October 2019.

 

For further information:

Cronin Group Plc

www.croningroupplc.com

Mark Warne, Executive Chairman

T: 0141 465 6871

Stockdale Securities Limited

T: 020 7601 6100

Tom Griffiths/Edward Thomas

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHKMMGZRMGGNZM
Date   Source Headline
28th Aug 20209:05 amRNSSecond Price Monitoring Extn
28th Aug 20209:00 amRNSPrice Monitoring Extension
19th Aug 20208:54 amRNSHolding(s) in Company
11th Aug 20204:13 pmRNSHolding(s) in Company
6th Aug 202012:30 pmRNSHolding(s) in Company
29th Jul 202012:16 pmRNSHolding(s) in Company
29th Jul 20209:45 amRNSHolding(s) in Company
29th Jul 20209:45 amRNSHolding(s) in Company
23rd Jul 20209:59 amRNSHolding(s) in Company
22nd Jul 20209:05 amRNSSecond Price Monitoring Extn
22nd Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20205:11 pmRNSHolding(s) in Company
14th Jul 20207:00 amRNSResults of Placing
13th Jul 20207:00 amRNSPlacing and Subscription to raise £2.1 million
2nd Jul 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20201:39 pmRNSResult of AGM and Directorate Change
4th Jun 20207:00 amRNSDigitalGlassware to Interface with Waters’ UNIFI
1st Jun 20204:41 pmRNSSecond Price Monitoring Extn
1st Jun 20204:36 pmRNSPrice Monitoring Extension
29th May 20207:00 amRNSFinal Results
26th May 20207:00 amRNSNotice of Results and Investor Presentation
11th May 202011:57 amRNSHolding(s) in Company
1st May 20208:21 amRNSHolding(s) in Company
28th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20207:00 amRNSContract with Cancer Research UK Beatson Institute
20th Feb 20207:00 amRNSCollaboration with the University of Nottingham
20th Feb 20207:00 amRNSCollaboration with the University of Nottingham
12th Feb 20207:00 amRNSDeepMatter collaborates with University of Leeds
24th Jan 20207:00 amRNSChange of Adviser
21st Jan 20206:10 pmRNSDirector/PDMR Shareholding
16th Dec 20197:00 amRNSDeepMatter Appoints Industry Advisors
9th Dec 20194:40 pmRNSSecond Price Monitoring Extn
9th Dec 20194:35 pmRNSPrice Monitoring Extension
9th Dec 201911:05 amRNSSecond Price Monitoring Extn
9th Dec 201911:00 amRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSDeepMatter collaboration with AstraZeneca
19th Sep 20197:00 amRNSInterim Results
12th Aug 20197:00 amRNSLaunch of DigitalGlassware Online Portal
8th Aug 20197:00 amRNSFirst revenues for DigitalGlassware
3rd Jul 20192:55 pmRNSChange of Registered Address
28th Jun 20197:00 amRNSDirectorate Change
21st Jun 201912:34 pmRNSChange of Adviser
3rd Jun 20193:41 pmRNSHolding(s) in Company
22nd May 201911:19 amRNSResult of AGM
12th Apr 20197:01 amRNSBoard Changes & Appointments to Advisory Committee
12th Apr 20197:00 amRNSFinal Results
11th Apr 20195:12 pmRNSHolding(s) in Company
10th Apr 201912:58 pmRNSHolding(s) in Company
4th Apr 20193:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.